Kikuchiûs Disease : √“¬ß“πºŸâªÉ
Transcription
90 «“√ “√»Ÿπ¬å°“√»÷°…“·æ∑¬»“ µ√å§≈‘π‘° ‚√ßæ¬“∫“≈æ√–ª°‡°≈â“ ªï∑’Ë 23 ©∫—∫∑’Ë 2 ‡¡.¬. - ¡‘.¬. 2549 √“¬ß“πºŸªâ «É ¬ Kikuchiûs Disease : √“¬ß“πºŸâªÉ«¬Àπ÷Ëß√“¬∑’Ë¡“ ¥â«¬µàÕ¡πÈ”‡À≈◊Õß∑’˧Ղµ «— ¥‘Ï ‡®’¬¡®‘µ æ.∫.* Abstract Kikuchiûs Disease Present with Cervical Lymphadenopathy : A Case Report Sawat Jaemjit M.D.* * Department Otolaryngology Maharat Naknon Ratchasima Hospital, Nakhonrachasima province, Thailand. J Prapokklao Hosp Clin Med Educat Center 2006;23:90-94. Kikuchiûs disease, also known as Kikuchi-Fujimoto disease or histiocytic necrotizing lymphadenitis that is a rare disease of cervical lymphadenitis. It mostly affects young Asian women and is being increasingly recognized in worldwide. It resolves spontaneously, usually over a period of several weeks to 3 months, rarely to 6 months. Cervical lymphadenopathy is the most prominent symptom and should be differentiated from lymphoproliferative, autoimmune and postinfectious diseases. A 37-year-old Thai woman with history of a left cervical mass for 6 month was persented with Kikuchiûs disease at Nakornratchasima regional hospital. ∫∑π” æ∫„π‡æ»À≠‘ß¡“°°«à“‡æ»™“¬ „π™à«ßÕ“¬ÿª≈“¬¬’Ë ‘∫ ªï∂÷ßµâπÕ“¬ÿ “¡ ‘∫ªï3 Õ“°“√· ¥ß¡“¥â«¬µàÕ¡πÈ”‡À≈◊Õß ∫√‘‡«≥§Õ‚µ ¡’ ‰¢â ÕàÕπ‡æ≈’¬ πÈ”Àπ—°≈¥ ª«¥µ“¡¢âÕ ¡â“¡‚µ ÕÕ°º◊Ëπ °“√¥”‡π‘π‚√§À“¬‰¥â‡Õß ‚¥¬„™â√–¬– ‡«≈“ 2-3 —ª¥“Àå ‰¡à‡°‘π 6 ‡¥◊Õπ Õ“°“√µàÕ¡πÈ”‡À≈◊Õß ∫√‘‡«≥§Õ‚µ¡—°®–‡ªìπÕ“°“√‡¥àπ ´÷Ëß∑”„ÀâµâÕß«‘π‘®©—¬ ·¬°‚√§ÕÕ°®“°‚√§„π°≈ÿ à ¡ lymphoproliferative, autoimmune, ·≈– postinfections Kikuchiûs disease ‡ªìπ‚√§∑’√Ë ®âŸ °— ¥’„π°≈ÿ¡à 欓∏‘ ·æ∑¬å·µà ”À√—∫∑“ß‚ µ »Õ π“ ‘° ¡’√“¬ß“πºŸâªÉ«¬ ‡ªìπ§√—Èß·√°‡¡◊ËÕªï æ.». 2528 ‚¥¬ Gleeson ·≈–§≥–4 Kikuchiûs disease À√◊Õ Kikuchi-Fujimoto disease À√◊Õ histiocytic necrotizing lymphadenitis ‡ªì π ‚√§∑’ Ë æ ∫‰¥â π â Õ ¬‚¥¬¡’ ° “√√“¬ß“π‡ªì π §√— È ß ·√° æ√âÕ¡°—π∑’ªË √–‡∑»≠’ªË πÉÿ ªï æ.».1972 ‚¥¬‡ªìπ√“¬ß“π ¢Õß Kikuchi1 °—∫√“¬ß“π¢Õß Fujimoto ·≈–§≥–2 √“¬ß“πºŸâªÉ«¬ à«π„À≠à®–Õ¬Ÿà „π∑«’ª‡Õ‡™’¬ ‡™àπ ≠’˪ÿÉπ ‡°“À≈’ ŒàÕß°ß ªí®®ÿ∫—π ¡’√“¬ß“πæ∫°√–®“¬∑—Ë«‚≈° “‡Àµÿ¢Õß‚√§¬—߉¡à∑√“∫·πà™—¥ ·µà¡’°“√ —ππ‘…∞“π«à“ ¿“«–µ‘¥‡™◊ÈÕ parasite, bacteria, EBV À√◊Õ‚√§„π°≈ÿà¡ autoimmune Õ“®®–‡ªìπªí®®—¬∑’Ë∑”„À⇰‘¥‚√§‰¥â ¡—° * °≈ÿà¡ß“π‚ µ »Õ π“ ‘°«‘∑¬“ ‚√ßæ¬“∫“≈¡À“√“™π§√√“™ ’¡“ ®—ßÀ«—¥π§√√“™ ’¡“ Vol. 23 No. 2 Apr. - Jun. 2006 J Prapokklao Hosp Clin Med Educat Center 91 µàÕ¡“‡√‘Ë¡¡’√“¬ß“π°“√µ√«®æ∫‚√§‡æ‘Ë¡¢÷Èπ¡“‡√◊ËÕ¬ Ê histiocytes admixed with cellular debris and nuclear ”À√— ∫ ª√–‡∑»‰∑¬¡’ √ “¬ß“πºŸ â ª É « ¬ 1 √“¬‚¥¬ dust. ¥—ß√Ÿª Fooanant S. ·≈–§≥–5 ‡π◊ÕË ß®“°ºŸªâ «É ¬∑’‡Ë ªìπ‚√§π’¡È °— ‰¥â √—∫°“√«‘π‘®©—¬‚√§®“°°“√µ—¥µàÕ¡πÈ”‡À≈◊Õß (lymph node biopsy) ∫√‘‡«≥§Õ‡æ◊ËÕµ√«®™‘Èπ‡π◊ÈÕ ¥—ßπ—Èπ·æ∑¬å ®÷ß§«√µ√–Àπ—°·≈–√–≈÷°∂÷ß‚√§π’È ‰«â¥â«¬·¡â®–‡ªìπ‚√§∑’Ë æ∫‰¥âπâÕ¬°Áµ“¡ √“¬ß“π©∫—∫π’È®÷ߢÕ𔇠πÕ√“¬ß“π ºŸªâ «É ¬1 √“¬∑’¡Ë “¥â«¬Õ“°“√µàÕ¡πÈ”‡À≈◊Õß∫√‘‡«≥§Õ‚µ·≈– ‰¥â√—∫°“√«‘π‘®©—¬‡ªìπ Kikuchiûs disease √“¬ß“πºŸªâ «É ¬ ºŸâªÉ«¬À≠‘߉∑¬Õ“¬ÿ 37 ªï Õ“™’æ√—∫®â“ß ∑’ËÕ¬Ÿà ®—ßÀ«—¥π§√√“™ ’¡“ ‰¥â‡¢â“√—∫°“√µ√«®√—°…“∑’Ë·ºπ° ÀŸ §Õ ®¡Ÿ° ‚√ßæ¬“∫“≈¡À“√“™ ®—ßÀ«—¥π§√√“™ ’¡“ ‡¡◊ËÕ‡¥◊Õπ°ÿ¡¿“æ—π∏å æ.». 2548 ¥â«¬Õ“°“√¡’°âÕπ∑’Ë§Õ ¢â“ߴ⓬¡“ª√–¡“≥ 6 ‡¥◊Õπ ºŸâªÉ«¬‰¡à¡’Õ“°“√‡®Á∫ ∫√‘‡«≥°âÕπ ‰¡à¡’ ‰¢â πÈ”Àπ—°§ß∑’Ë ‰¡à¡’Õ“°“√√à«¡Õ◊Ëπ Ê µ√«®√à“ß°“¬æ∫°âÕπ¢π“¥ ‡ âπºà“π»Ÿπ¬å°≈“ß 1.5 ‡´πµ‘‡¡µ√ ∑’Ë∫√‘‡«≥ posterior triangle ¢Õß§Õ¥â“π´â“¬°âÕπ¡’≈—°…≥– firm, movable, not tender, smooth surface µ√«® √à“ß°“¬„π‚æ√ß®¡Ÿ° À≈—ß‚æ√ß®¡Ÿ° „π™àÕߪ“° ™àÕß§Õ ·≈–°≈àÕß ‡ ’¬ß ‰¡àæ∫§«“¡º‘¥ª°µ‘Õ◊Ëπ Ê º≈µ√«®∑“ßÀâÕߪؑ∫µ— °‘ “√ CBC æ∫ Hct 39.6% WBC 10,000 (NE 65%, LY 21 %, MO 7 %) Plt 362,000 ·≈– Anti HIV - ve À≈—ß®“°ºŸâªÉ«¬‰¥â√—∫¬“ªØ‘™’«π– cloxacillin 500 mg. «—π≈– 4 §√—Èß π“π 2 —ª¥“Àå æ∫«à“ °âÕπ‰¡à¬ÿ∫≈ß ®÷߇¢â“√—∫°“√ºà“µ—¥°âÕπ (excision biopsy) ‡æ◊ËÕµ√«®∑“ßæ¬“∏‘«‘∑¬“ °âÕπµàÕ¡πÈ”‡À≈◊Õß¡’≈—°…≥– ∑“ß®ÿ≈欓∏‘«‘∑¬“ §◊Õ The lymph node architecture is partially maintained and residual follicles show reactive germinal centers. Geographic large areas of necrosis is seen. The necrosis consists of nuclear fragments surrounded by large accumulations of palely staining °“√«‘π‘®©—¬§◊Õ acute necrotizing histiocytic lymphadenitis À√◊Õ Kikuchiûs disease ¿“¬À≈—ß®“° ºà“µ—¥°âÕπ·≈–µ√«®µ‘¥µ“¡ºŸâªÉ«¬π“π 6 ‡¥◊Õπ (®π∂÷ß ¢≥–π’È) æ∫«à“≈—°…≥–∫“¥·º≈À“¬‡ªìπª°µ‘¥’ ‰¡à¡’°âÕπ ·≈–ºŸâªÉ«¬‰¡à¡’Õ“°“√º‘¥ª°µ‘·µàÕ¬à“ß„¥ «‘®“√≥å Kikuchiûs disease ‡ªìπ‚√§∑’Ëæ∫∫àÕ¬„π∑«’ª ‡Õ‡™’¬„πÕ—µ√“‡æ»À≠‘ßµàՇ滙“¬‚¥¬ª√–¡“≥ 3-4: 16 ‚¥¬¡—°®–æ∫„π™à«ßÕ“¬ÿª≈“¬¬’Ë ‘∫ªï∂÷ßµâπÕ“¬ÿÀâ“ ‘∫ªï (Õ“¬ÿ‡©≈’ˬ 30 ªï) æ∫¡“°„πª√–‡∑»≠’˪ÿÉπ·≈–‡ªìπ ª√–‡∑»·√°∑’Ë¡’√“¬ß“πæ∫ºŸâªÉ«¬ µàÕ¡“®÷ß¡’√“¬ß“π °“√µ√«®æ∫‚√§™π‘¥π’È„πª√–‡∑»Õ◊Ëπ Ê ∑—Ë«‚≈° “‡Àµÿ¢Õß°“√‡°‘¥‚√§¬—߉¡à∑√“∫·πà™¥— ‰¡àæ∫ «à“æ—π∏ÿ°√√¡À√◊Õ ¿“æ·«¥≈âÕ¡‡ªìπªí®®—¬„À⇰‘¥‚√§∑’Ë ™—¥‡®π·µà¡’¢âÕ —ππ‘∞“π«à“Õ“®¡’ “‡Àµÿ®“°°“√µ‘¥‡™◊ÈÕ µà“ß Ê7 ‡™àπ ¿“«–°“√µ‘¥‡™◊ÈÕ®“°‰«√— ( rubella virus, paramyxovirus ·≈–parainfluenza virus ) À√◊Õ °“√ µ‘¥‡™◊ÈÕ®“°ª“√“ ‘µ (toxoplasma) ·≈–°“√µ‘¥‡™◊ÈÕ®“° ·∫§∑’‡√’¬ (Yersinia enterocolitica)3,7 Õ“°“√·≈–Õ“°“√· ¥ß ¡“°°«à“À√◊Õ‡∑à“°—∫ √â Õ ¬≈– 80 3,6,7,8,9 ¢ÕߺŸ â ª É « ¬¡— ° ®–¡“æ∫·æ∑¬å ¥ â « ¬ Õ“°“√µàÕ¡πÈ”‡À≈◊Õß∑’˧Ղµ ‰¡à¡’Õ“°“√‡®Á∫∑’˰âÕπ8 À√◊Õ‡®Á∫πâÕ¬ (mild tender)3 ‚¥¬ºŸâªÉ«¬∑’Ë¡’°âÕπµàÕ¡πÈ” ‡À≈◊Õß∑’˧Ղµ¡—°æ∫∑’Ë∫√‘‡«≥ posterior triangle √âÕ¬≈– 65-70 ·≈–æ∫∫√‘‡«≥Õ◊Ëπ Ê ‰¥âπâÕ¬ ‡™àπ axillary node 92 «“√ “√»Ÿπ¬å°“√»÷°…“·æ∑¬»“ µ√å§≈‘π‘° ‚√ßæ¬“∫“≈æ√–ª°‡°≈â“ √âÕ¬≈– 149 À√◊Õ supraclavicular node √âÕ¬≈– 129 „π®”π«ππ’È√âÕ¬≈– 79 ‡ªìπºŸâªÉ«¬∑’Ë¡’°âÕπµàÕ¡πÈ”‡À≈◊Õß ‚µ¢â“߇¥’¬« (unilateral cervical) à«π∑’ˇÀ≈◊Õ√âÕ¬≈– 21 ‡ªìπºŸâªÉ«¬∑’Ëæ∫°âÕπ‚µ∑—Èß Õߢâ“ß (bilateral cervical) ¢π“¥¢Õß°âÕπ à«π„À≠àæ∫‰¥âµ—Èß·µà 1-4 ´¡.·µàÕ“®æ∫ °âÕπ‚µ¢π“¥ 5-6 ´¡.‰¥â „π∫“ß√“¬6 πÕ°®“°π’ÈÕ“®æ∫ Õ“°“√Õ◊ËπÊ√à«¡¥â«¬‡™àπ ¡’ ‰¢â µ—∫¡â“¡‚µ ª«¥»’√…– §≈◊Ëπ‰ â Õ“‡®’¬π º◊Ëπ∑’˺‘«Àπ—ß ª«¥¢âÕ ·≈–Õ◊Ëπ Ê Kikuchiûs disease ¡’§«“¡ —¡æ—π∏å°—∫‚√§ SLE ‚¥¬Õ“®®–«‘π‘®©—¬‡ªìπ‚√§‰¥âæ√âÕ¡°—πµ—Èß·µà‡√‘Ë¡µâπ À√◊Õ¿“¬À≈—ß®“°«‘π‘®©—¬‚√§ Kikuchiûs disease ·≈â« ®÷ßµ√«®æ∫‚√§ SLE ´÷ËßÕ“®„™â√–¬–‡«≈“µ—Èß·µà 10 ‡¥◊Õπ ∂÷ß 3 ªï10 ¥—ßπ—Èπ®÷ß§«√¡’°“√µ‘¥µ“¡°“√√—°…“ºŸâªÉ«¬„π √–¬–¬“« ·≈–‡ΩÑ“√–«—ß°“√‡°‘¥‚√§ SLE √à«¡¥â«¬ °“√«‘π®‘ ©—¬·¬°‚√§ ‡π◊ÕË ß®“°ºŸªâ «É ¬¡—°®–¡“¥â«¬ Õ“°“√¡’µàÕ¡πÈ”‡À≈◊Õß∑’˧Ղµ °“√«‘π‘®©—¬·¬°‚√§¡—°®– Õ¬Ÿà „π°≈ÿà¡‚√§¥—ßµàÕ‰ªπ’È 1. °“√µ‘¥‡™◊ÕÈ ( infection) ‡™à𠉫√— ·∫§∑’‡√’¬ ª“√“ ‘µ 2. Autoimmune ‡™àπ SLE 3. Malignant ‡™àπ lymphoma ‡π◊ËÕß®“° Kikuchiûs disease ¡—°‰¥â√—∫°“√«‘π‘®©—¬‚√§º‘¥‡ªìπ lymphoma ‰¥â∂÷ß√âÕ¬≈– 408, metastatic carcinoma °“√µ√«®∑“ßÀâÕߪؑ∫—µ‘°“√‰¡à “¡“√∂¬◊π¬—π °“√«‘π‘®©—¬‰¥â ·µà™à«¬„π°“√«‘π‘®©—¬·¬°‚√§Õ◊Ëπ11 ‡™àπ SLE ºŸâªÉ«¬¥â«¬‚√§ Kikuchi ª√–¡“≥√âÕ¬≈– 503 ¡—°æ∫ ¿“«–‡¡Á¥‡≈◊Õ¥¢“«µË”‡≈Á°πâÕ¬ (mild granulocytopenia) ·≈–Õ“®®–æ∫§à“ ESR ·≈– C- reactive protein Ÿß3 πÕ°®“°π—Èπ°“√∑” fine needle aspiration (FNA) ¢ÕßµàÕ¡πÈ”‡À≈◊Õß Õ“®®–™à«¬„π°“√ π—∫ πÿπ °“√«‘π‘®©—¬ (suggest) ·µà ‰¡à “¡“√∂„™â „π°“√«‘π‘®©—¬ ‚√§‰¥âÕ¬à“߉√ °Áµ“¡≈—°…≥–®”‡æ“– (typical finding) ∑’Ëæ∫‰¥â „π°“√µ√«® fine needle aspiration 3 §◊Õ lymphocytes (small and atypical), reactive phagocytic histiocytes, and çintense extracellular debrisé ªï∑’Ë 23 ©∫—∫∑’Ë 2 ‡¡.¬. - ¡‘.¬. 2549 ”À√—∫ definite diagnosis ¢Õß‚√§ Kikuchiûs „™â«‘∏’°“√µ—¥°âÕπµàÕ¡πÈ”‡À≈◊Õß (lymph node biopsy) ¡“µ√«®®ÿ≈欓∏‘«‘∑¬“ (histopathology) ´÷Ëß®–æ∫ 欓∏‘ ¿“æ histopathology ‰¥â 3 ≈—°…≥– §◊Õ proliferative, necrotizing ·≈– xanthomatous3,12 ´÷Ëß®– µâÕßæ∫¢âÕ∫àß™’È (critiria)6 µ“¡≈—°…≥–µàÕ‰ªπ’È 1. patchy irregular areas of eosinophilic necrosis in the paracortex and/or cortex 2. pronounced fragments of nuclear dust distributed in an irregular fashion through the area of necrosis 3. absence of granulocytes and paucity of plasma cells 4. clusters of plasmacytoid T cells, or plasmacytoid monocytes, and 5. numerous immunoblasts ( transformed lymphocytes, predominantly of T cell phenotype). à«π„À≠ຟâªÉ«¬∑’ˇªìπ‚√§ Kikuchiûs ®–¡’Õ“°“√ ¥’¢÷Èπ¿“¬„π 2-3 —ª¥“Àå ·≈–À“¬‰¥â‡Õß (self limited disease) ‚¥¬√–¬–‡«≈“°“√¥”‡π‘π‚√§‰¡à‡°‘π 6 ‡¥◊Õπ3 ·≈–‰¡àµâÕß°“√°“√√—°…“∑’Ë®”‡æ“– À≈—°¢Õß°“√√—°…“ ‚√§„™â«‘∏’°“√√—°…“·∫∫ª√–§—∫ª√–§Õß (supportive) ‚¥¬°“√„™â¬“„π°≈ÿà¡ nonsteroidal anti- inflammatory drug9 ¬°‡«âπ„π√“¬∑’Ë¡’ªí≠À“À√◊Õæ∫√à«¡°—∫‚√§Õ◊Ëπ Ê ‡™àπ SLE ´÷Ëß®–„À⬓„π°≈ÿà¡ corticosteroid6 Õ¬à“߉√ °Áµ“¡¡’ºŸâªÉ«¬∫“ß√“¬∑’Ë¡’Õ“°“√π“π‰ª°«à“π’È ‰¥â ®÷ß¡’ √“¬ß“π∫“ß©∫—∫‡ πÕ„Àℙ⫑∏’ excision biopsy ‡æ◊ËÕ µ—¥°âÕπ∑’Ë¡’欓∏‘ ¿“æÕÕ° ´÷Ëß®–™à«¬∑”„À⺟âªÉ«¬À“¬ ®“°‚√§‰¥â‡√Á«¬‘Ëߢ÷Èπ8,9 °“√°≈—∫‡ªìπ´È” (recurrence of the disease) æ∫ºŸâªÉ«¬√âÕ¬≈– 3.310,12 °≈—∫¡“‡ªìπ‚√§π’ȴȔՒ°¿“¬„π √–¬–‡«≈“ 4-7 ªï À≈—ß®“°°“√«‘π‘®©—¬‚√§§√—Èß·√° ‚¥¬„π°≈ÿà¡∑’˰≈—∫¡“‡ªìπ‚√§´È”Õ’°√âÕ¬≈– 80 æ∫°âÕπ µàÕ¡πÈ”‡À≈◊Õ߬ÿ∫À“¬‰¥â‡Õß¿“¬„π 6 ‡¥◊Õπ ‚¥¬‰¡à ‰¥â√—∫ °“√√—°…“„¥ Ê ¡’√“¬ß“πæ∫ºŸâªÉ«¬ Kikuchiûs ‡ ’¬™’«‘µ 2 √“¬ Vol. 23 No. 2 Apr. - Jun. 2006 ‚¥¬ºŸâªÉ«¬ 1 √“¬ “‡Àµÿ°“√µ“¬‡π◊ËÕß®“° lupus-like syndrome13 √“¬∑’Ë 2 “‡Àµÿ°“√µ“¬‡π◊ËÕß®“°À—«„® ≈⡇À≈«·∫∫‡©’¬∫æ≈—π (sudden heart failure)¿“¬ À≈—ß®“°°“√µ—¥°âÕπµàÕ¡πÈ”‡À≈◊Õß∑’˧ա“µ√«®‰¥â‡æ’¬ß 72 ™¡.14 √ÿª ‚√§ Kikuchiûs ‡ªìπ‚√§∑’Ëæ∫‰¥âπâÕ¬·≈–‡ªìπ ‚√§∑’ËÀ“¬‰¥â‡Õß¿“¬„π√–¬–‡«≈“ª√–¡“≥ 6 ‡¥◊Õ𠇪ìπ‚√§∑’Ë¡’§«“¡ ”§—≠∑’Ë®–µâÕß«‘π‘®©—¬·¬°‚√§Õ◊Ëπ Ê ∑’Ë ‡ªìπÕ—πµ√“¬∑’Ë∑”„À⇰‘¥µàÕ¡πÈ”‡À≈◊Õß∑’˧Ղµ ‡π◊ËÕß®“° °“√¥”‡π‘π‚√§·≈–°“√√—°…“¡’§«“¡·µ°µà“ß°—π‡ªìπ Õ¬à“ß¡“°°—∫‚√§Õ◊ËπÊ ‚¥¬°“√∑” excision biopsy „π √“¬∑’Ë¡’µàÕ¡πÈ”‡À≈◊Õß‚µπ“π°«à“ Õß —ª¥“Àå Referrences 1. Kikuchi M. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytes : a clinicopathological stuty. Nippon Ketsueki Gakkai Zasshi 1972;35: 379-80. 2. Fujimoto Y,Kojima Y, Yamaguchi K. Cervical subacute necrotizing lymphadenitis. Naika 1972;30:920-7. 3. Baumgartner BJ, Helling ER. Kikuchiûs disease: a case report and review of the literature. ENTJ 2002;81:331-5. 4. Gleeson MJ,Siodlak MZ, Barbatis C, Salama NY. Kikuchiûs disdase-: a new cause of cervical lymphadenopathy. J Laryngol Otol 1985;99:935-9. J Prapokklao Hosp Clin Med Educat Center 93 5. Fooanant S, Sriuthaisiriwong P, Kanchanarak C, Hanprasertpong J, Chaiwan B.Kikuchiûs disease presented with lateral neck cellutis, parotidomegaly and enlargement of sternocleidomastoid muscle. ‡Õ° “√°“√ ª√–™ÿ¡«‘™“°“√√“™«‘∑¬“≈—¬‚ µ »Õ π“ ‘° ·æ∑¬å ·Ààߪ√–‡∑»‰∑¬ ª√–®”ªï 2/2547. 6. Lin HC, Su CY, Huang CC, Hwang CF, Chien CY. Kikuchiûs disease : a review and analysis of 61 cases Otolaryngol Head Neck Surg ªï ;128:650-3. 7. Yu HL, Lee SSJ, Tsai HC, HuangCK, Chen YS, Lin HH, et al. Clinical manifestations of Kikuchi, s disease in southern Taiwan. Microbiol Immunal Infect 2005;38-40. 8. Ramirez AL, Johnson J, Murr AH, KikuchiFujimotoûs disease : an easily misdiagnosed clinical entity Otolaryngol Head Neck Surg 2001;651-3. 9. Garcia CE, Girdhad-Gopad HV, Dofman DM.Kikuchi-Fujimoto disease of the neck : update : Update. Ann Oto Rhino Laryngol 1993;102:11-5. 10. Wang TJ, YANG YH, Lin YT, Chiang BL. Kikuchi-Fujimoto disease in children : clinical features and disease course. J Microbiol Immunal Infect 2004;37:219-24. 11. Koybasi S, Saydam L, Gungen Y, Histiocytic necrotizing lymphadenitis of the eck.Am J Otolaryngol 2003;24:344-7. 12. Kuo TT. Kikuchiûs disease (histiotycite) necrotizing lymphadenitis). A clinicopathologic study of 79 cases with an analysis of histologic subtypes, immunohistology, and ploidy. Am J Surg Pathol 1995;19:798-809. 94 «“√ “√»Ÿπ¬å°“√»÷°…“·æ∑¬»“ µ√å§≈‘π‘° ‚√ßæ¬“∫“≈æ√–ª°‡°≈â“ 13. Chan JK, Wong KC, Ng CS. A fatal case of multicentric Kikuchiûs histiocytic necrotizing lymphadenitis. Cancer 1989;63:1856-62. 14. Lin SH, Ko WS, Lee HS, Hwang WS. Kikuchiûs disease associated with lupus like syndrome-a fatal case [letter]. J Rheumatol 1992;19:1995-6. ªï∑’Ë 23 ©∫—∫∑’Ë 2 ‡¡.¬. - ¡‘.¬. 2549
Documents pareils
How Experts Do It Unimproved GERD After PPI Treatment
μÕ∫ æ∫‰¥â§Õà π¢â“ß∫àÕ¬ ∂ⓇªìπºŸªâ «É ¬∑’¡Ë “¥â«¬Õ“°“√ heartburn, regurgitation
¡—°μÕ∫ πÕßμàÕ PPI ¥’ ·μà∑’ˉ¡àμÕ∫ πÕß¡—°‡ªìπæ«°∑’Ë¡’Õ“°“√∑“ß ENT À√◊Õ¡’
·§àÕ“°“√≈¡μ’¢÷ÈπÕ°À√◊Õ§Õ ·μà∂Ÿ°«‘π‘®©—¬º‘¥«à...
4 Single femoral
‡¡◊ËÕ‡ª√’¬∫‡∑’¬∫º≈°“√∑” FNB μàÕ°“√‡ √‘¡§«“¡
“¡“√∂„π°“√√–ß—∫ª«¥„π√–¬–À≈—ß°“√ºà“μ—¥ ‚¥¬‡©æ“–„π
24 ™—Ë«‚¡ß·√°À≈—ß°“√ºà“μ—¥ ®“°°“√»÷°…“π’ȉ¡àæ∫«à“ºŸâªÉ«¬
∑—Èß 2 °≈ÿà¡ μâÕß°“√¬“°≈ÿà¡ opioids ‡æ‘Ë¡‡μ‘¡„...
Unilateral Blindness as a First Sign of Bronchogenic Carcinoma
patients, especially who have another neurologic deficits or known cancer should bring to mind the diagnosis
of meningeal carcinomatosis. Thai J Ophthalmol 2008; January-June 22(1): 77-81.
π«∑“ß°“√«`π`
amination §«√∑”°“√µ—¥™‘Èπ‡π◊ÈÕ‡æ◊ËÕ àßµ√«® histology ∑ÿ°√“¬
17. À≈—°°“√√—°…“‡À¡◊Õπ„π¢âÕ 13 [LSM/Intensify treatment (1)] ·µà
∂⓺ŸâªÉ«¬Õ“°“√¬—߉¡à¥’¢÷Èπ¢π“¥¢Õß H2RA Õ“®‡æ‘Ë¡‡ªìπ 2 ‡∑à“‰¥â ‡™àπ
„Àâ ...
§≈`π`°æàÕ ·¡à§ π‡°àß „π‚√ßæ¬“∫“≈ àß ‡ √`¡ ÿ¢ ¿“æ ®.™≈∫ÿ√`
·¡à·≈–‡¥Á°µ—Èß·µà°“√Ω“°§√√¿å®π∂÷ß°“√§≈Õ¥ ¥—ß
¢âÕ¡Ÿ≈Õπ“¡—¬·¡à·≈–‡¥Á°ª√–‡∑»‰∑¬ªïæ.». 2545 æ∫
Õ—µ√“ à«π°“√µ“¬¢Õß¡“√¥“ 22.1:100,000 °“√‡°‘¥¡’
™’æ Õ—µ√“°“√µ“¬ª√‘°”‡π‘¥ 9.2:1000 °“√‡°‘¥∑—ÈßÀ¡¥
Õ—µ√“°“√¢“...
7 ¿“«–æ`… ª“π„®
‰¡‚§√°√—¡μàÕ™—Ë«‚¡ß ª–∫√‘‡«≥º‘«Àπ—ß∑ÿ° 72 ™—Ë«‚¡ß ¥—ßπ—Èπ
®÷ß„Àâ‡æ‘Ë¡ transdermal fentanyl ‡ªìπ¢π“¥ 50 ‰¡‚§√°√—¡μàÕ
™—Ë«‚¡ß √à«¡°—∫„À⬓‡ √‘¡ pregabalin 75 ¡‘≈≈‘°√—¡ ·≈– nortriptyline 10 ¡‘≈≈‘°√—¡ ...